Kuaban, C <br/><br/>
High effectiveness of a 12-month regimen for MDR-TB patients in Cameroon.  [electronic resource] 

 -  The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease  May 2015 
 - 517-24 p.  digital 
<br/><br/> Publication Type: Journal Article; Observational Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1815-7920 
<br/><br/><label>Standard No.: </label>10.5588/ijtld.14.0535  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Antitubercular Agents--adverse effects<br/>Cameroon<br/>Clofazimine--therapeutic use<br/>Cohort Studies<br/>Confidence Intervals<br/>Developing Countries<br/>Dose-Response Relationship, Drug<br/>Drug Administration Schedule<br/>Drug Therapy, Combination<br/>Drug-Related Side Effects and Adverse Reactions--epidemiology<br/>Ethambutol--therapeutic use<br/>Female<br/>Fluoroquinolones--therapeutic use<br/>Gatifloxacin<br/>Humans<br/>Isoniazid--therapeutic use<br/>Kanamycin--therapeutic use<br/>Male<br/>Middle Aged<br/>Odds Ratio<br/>Prospective Studies<br/>Prothionamide--therapeutic use<br/>Pyrazinamide--therapeutic use<br/>Risk Assessment<br/>Time Factors<br/>Treatment Outcome<br/>Tuberculosis, Multidrug-Resistant--diagnosis<br/>Young Adult<br/>Assessment of Medication Adherence